Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae.

about

Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment Mycoplasma pneumoniae-derived lipopeptides induce acute inflammatory responses in the lungs of mice.Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.

P2860

Q26742180-F5645049-E186-4F9A-BC4D-85145A5B6E1C Q41911556-EC747E68-53AA-40DA-B093-0A15104B6A00 Q51595534-360B917E-A09C-4F33-A152-18CD8A869798

P2860

Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae.

Item

http://www.wikidata.org/entity/Q42747636

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Activity of Garenoxacin agains ...... sistant Mycoplasma pneumoniae.

@en

Activity of Garenoxacin agains ...... sistant Mycoplasma pneumoniae.

@nl

type

Item

label

Activity of Garenoxacin agains ...... sistant Mycoplasma pneumoniae.

@en

Activity of Garenoxacin agains ...... sistant Mycoplasma pneumoniae.

@nl

prefLabel

Activity of Garenoxacin agains ...... sistant Mycoplasma pneumoniae.

@en

Activity of Garenoxacin agains ...... sistant Mycoplasma pneumoniae.

@nl

P1476

Activity of Garenoxacin agains ...... sistant Mycoplasma pneumoniae.

@en

P2093

Masahiro Takahata

http://www.w3.org/2001/XMLSchema#string

Tsuguo Sasaki

http://www.w3.org/2001/XMLSchema#string

Tsutomu Yamazaki

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone

Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae.

Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.

In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas

Azithromycin. A review of its use in paediatric infectious diseases.

Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibil

Erythromycin resistance by ribosome modification.

Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae.

In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively

In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas.

P304

2278-2279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01561-06

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6420737

http://www.w3.org/2001/XMLSchema#string

P698

17387152

http://www.w3.org/2001/XMLSchema#string

P921

gatifloxacin

P932

1891417

http://www.w3.org/2001/XMLSchema#string

Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae.

about

P2860

P2860

Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932